AlphaRM analytical company presented the results of the audit covering the retail and state pharmaceutical market in Russia for the first seven months of 2023.

According to the data obtained, the Pharmasyntez Group ranked first in the segment of government procurement of pharmaceuticals and became the leader among the manufacturers of antineoplastic drugs by volume for the entire reporting period.

In addition, the company ranked first among domestic manufacturers of cytostatic hormones by value and in the segment of anti-tuberculosis drugs by volume.

Pharmasyntez also ranked first in the segment of government procurement related to hospital solutions.

In addition, the company was among the top 5 manufacturers of systemic antibiotics purchased by the government.

In the OTC drugs segment, Pharmasyntez showed a 9-fold increase in shipment dynamics and entered the list of the largest manufacturers, according to RNC Pharma data. This is an important achievement that emphasizes the trust of both consumers and doctors in the company's products.